PharmSync: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PharmSync
Largest movements
- Cash +€62,424
up €62,424 (+114.2%), from €54,668 to €117,092
mainly Net result for the year (+€57,846) and Trade debts (+€21,752)
- Receivables within one year +€16,807
up €16,807 (+750.6%), from €2,239 to €19,046
of which Trade receivables: +€16,807
- Profit (loss) carried forward +€57,846
up €57,846 (+132.2%), from €43,743 to €101,589
- Trade debts +€21,752
up €21,752 (+2259.6%), from €963 to €22,715
- Gross operating margin +€17,824
up €17,824 (+30.9%), from €57,723 to €75,547
- Taxes +€3,132
up €3,132 (+24.5%), from €12,789 to €15,922
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €57,767 | €136,689 | +€78,922 | +136.6% |
| Fixed assets | 21/28 | €400 | €400 | = | 0.0% |
| Financial fixed assets | 28 | €400 | €400 | = | 0.0% |
| Current assets | 29/58 | €57,367 | €136,289 | +€78,922 | +137.6% |
| Amounts receivable within one year | 40/41 | €2,239 | €19,046 | +€16,807 | +750.6% |
| Trade receivables | 40 | €2,113 | €18,920 | +€16,807 | +795.4% |
| Other amounts receivable | 41 | €126 | €126 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €54,668 | €117,092 | +€62,424 | +114.2% |
| Deferred charges and accrued income | 490/1 | €460 | €152 | -€309 | -67.1% |
| Total equity and liabilities | 10/49 | €57,767 | €136,689 | +€78,922 | +136.6% |
| Equity | 10/15 | €46,743 | €104,589 | +€57,846 | +123.8% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €43,743 | €101,589 | +€57,846 | +132.2% |
| Amounts payable | 17/49 | €11,024 | €32,100 | +€21,076 | +191.2% |
| Amounts payable within one year | 42/48 | €11,024 | €32,100 | +€21,076 | +191.2% |
| Trade debts | 44 | €963 | €22,715 | +€21,752 | +2259.6% |
| Suppliers | 440/4 | €963 | €22,715 | +€21,752 | +2259.6% |
| Taxes, remuneration and social security | 45 | €9,877 | €9,221 | -€656 | -6.6% |
| Taxes | 450/3 | €9,877 | €9,221 | -€656 | -6.6% |
| Other amounts payable | 47/48 | €184 | €164 | -€20 | -10.9% |
| Other operating charges | 640/8 | €118 | €386 | +€268 | +227.0% |
| Gross operating margin | 9900 | €57,723 | €75,547 | +€17,824 | +30.9% |
| Operating profit (loss) | 9901 | €57,605 | €75,161 | +€17,556 | +30.5% |
| Financial income | 75/76B | €0 | €85 | +€85 | +284100.0% |
| Recurring financial income | 75 | €0 | €85 | +€85 | +284100.0% |
| Financial charges | 65/66B | €1,073 | €1,478 | +€406 | +37.8% |
| Recurring financial charges | 65 | €1,073 | €1,478 | +€406 | +37.8% |
| Profit (loss) for the period before taxes | 9903 | €56,532 | €73,768 | +€17,236 | +30.5% |
| Income taxes | 67/77 | €12,789 | €15,922 | +€3,132 | +24.5% |
| Profit (loss) for the period | 9904 | €43,743 | €57,846 | +€14,103 | +32.2% |
| Profit (loss) for the period to be appropriated | 9905 | €43,743 | €57,846 | +€14,103 | +32.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.